Arrowstreet Capital, Limited Partnership Care Dx, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $1.03 Million - $1.6 Million	-129,006 Reduced 37.3%	216,891 $2.3 Million
Q4 2023 Feb 14, 2024	BUY	$4.9 - $12.86 $1.69 Million - $4.45 Million	345,897 New	345,897 $4.15 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $490,280 - $875,839	-11,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$59.15 - $91.99 $745,290 - $1.16 Million	-12,600 Reduced 51.43%	11,900 $754,000
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $1.05 Million - $1.58 Million	16,600 Added 210.13%	24,500 $2.24 Million
Q1 2021 May 14, 2021	BUY	$57.62 - $95.6 $455,198 - $755,240	7,900 New	7,900 $538,000
Q4 2020 Feb 12, 2021	SELL	$41.43 - $77.09 $858,595 - $1.6 Million	-20,724 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$30.88 - $37.94 $639,957 - $786,268	20,724 New	20,724 $786,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.